Results 41 to 50 of about 10,814 (230)
Effects of Metformin on Spontaneous and Clomiphene-Induced Ovulation in the Polycystic Ovary Syndrome [PDF]
, 1998 Background Obese women with the polycystic ovary syndrome are relatively unresponsive to the induction of ovulation by clomiphene. We hypothesized that reducing insulin secretion by administering metformin would increase the ovulatory response to ...
Evans, William S., , M.D. +3 more
core +2 more sources
Andrology, EarlyView.ABSTRACT Background Male hypogonadotropic hypogonadism typically presents with azoospermia and is one of the few causes of infertility amenable to a medical intervention. Gonadotropin therapy offers a chance to restore spermatogenesis and fertility in these individuals.
Manou Huijben +3 more
wiley +1 more source
Is there a future for ovulation induction in the current era of assisted reproduction? [PDF]
, 2003 The clinical use of medical induction of ovulation in normogonadotrophic anovulatory women (WHO II), including polycystic ovary syndrome, is increasingly questioned.
Fauser, B.C.J.M. (Bart) +1 more
core +2 more sources
Clomiphene citrate and ovulation induction
Reproductive BioMedicine Online, 2002 Clomiphene can be used to treat anovulation due to hypothalamus or pituitary gland dysfunction, and it normalizes the luteal phase in stimulated patients. It can be used to estimate ovarian follicle reserve, and may be predictive of ovulation in women aged >/=35 years or with failed IVF.
Sovino, Hugo +2 more
openaire +3 more sources
Testosterone Versus Clomiphene Treatment of Hypogonadism: A Retrospective Analysis in US Veterans
Andrology, EarlyView.ABSTRACT Background Male hypogonadotropic hypogonadism is a complex condition with a multifactorial etiology. Although testosterone replacement therapy (TRT) is the only approved treatment for male hypogonadism, clomiphene citrate (CC) is often used as an off‐label treatment.
Shourya Tadisina +6 more
wiley +1 more source
Metformin in polycystic ovary syndrome: systematic review and meta-analysis [PDF]
, 2003 The original publication may be found at www.bmj.comObjective To assess the effectiveness of metformin in improving clinical and biochemical features of polycystic ovary syndrome. Design Systematic review and meta-analysis.
Flight, I., Lord, J., Norman, R.
core +1 more source
American Journal of Medical Genetics Part A, Volume 200, Issue 6, Page 1452-1457, June 2026.ABSTRACT FOXA2 (hepatocyte nuclear factor‐3β, HNF‐3β) encodes a transcriptional activator involved in early embryogenesis, particularly in the patterning and differentiation of midline structures such as the neural tube, foregut, and pituitary gland. Its role in human pathogenesis was first suspected when patients with deletion of chromosome 20p11.2 ...
Christopher Connolly +3 more
wiley +1 more source
Clinical Medicine Insights: Reproductive Health, 2011 Background Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies affecting women in the reproductive age group, and is one of the most common causes of hyperandrogenic anovulatory infertility. The aromatase inhibitor, letrozole, has
Sherif F. Hendawy +2 more
doaj +1 more source
Catamenial haemoptysis and clomiphene citrate therapy [PDF]
Thorax, 2003 Case reports of catamenial haemoptysis are uncommon. We report the first case of thoracic endometriosis associated with clomiphene citrate therapy and previously unpublished endobronchial and angiographic findings.
B, Hope-Gill, B V, Prathibha
openaire +2 more sources
Analytical Science Advances, Volume 7, Issue 1, June 2026.ABSTRACT Misuse of performance‐enhancing substances in sport remains a persistent threat to the values of fair competition, with estimated doping prevalence far exceeding adverse analytical findings in routine testing. This highlights the need for improved surveillance tools capable of rapid and simple, on‐site screening methods.
Alisha Henderson +7 more
wiley +1 more source